Carrie Jo Smith-hunter, in Burkesville, KY - Occupational Therapist

Carrie Jo Smith-hunter, is a Occupational Therapist based in Burkesville, Kentucky. Carrie Jo Smith-hunter is licensed to practice in Kentucky (license number ) and her current practice location is Cumberland Valley Manor, 301 S Main Street, Burkesville, Kentucky. She can be reached at her office (for appointments etc.) via phone at (270) 864-4315.

NPI number for Carrie Jo Smith-hunter is 1447926464 and her current mailing address is 1406 Mount Hermon Rd, Mount Hermon, Kentucky. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1447926464.

Contact Information

	Carrie Jo Smith-hunter,
	Cumberland Valley Manor, 301 S Main Street, Burkesville, KY 42717
	(270) 864-4315
	Not Available

Healthcare Provider's Profile

Full Name	Carrie Jo Smith-hunter
Gender	Female
Speciality	Occupational Therapist
Location	Cumberland Valley Manor, Burkesville, Kentucky
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1447926464
Provider Enumeration Date: 08/19/2021
Last Update Date: 08/19/2021

Medical Identifiers

Medical identifiers for Carrie Jo Smith-hunter such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1447926464	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	(Kentucky)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Carrie Jo Smith-hunter is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Carrie Jo Smith-hunter, 1406 Mount Hermon Rd, Mount Hermon, KY 42157-8043 Ph: (270) 427-8790	Carrie Jo Smith-hunter, Cumberland Valley Manor, 301 S Main Street, Burkesville, KY 42717 Ph: (270) 864-4315

News Archive

Scientists identify how mRNA deciphers critical information within genetic code

Case Western Reserve scientists have discovered that speed matters when it comes to how messenger RNA (mRNA) deciphers critical information within the genetic code — the complex chain of instructions critical to sustaining life. The investigators' findings, which appear in the March 12 journal Cell, give scientists critical new information in determining how best to engage cells to treat illness — and, ultimately, keep them from emerging in the first place.

Cancer patients more likely to die following surgery in lower-income countries

Research by an international team of medical experts has found cancer patients could be up to four times more likely to die following cancer surgery in low to lower-middle income countries than in high-income countries.

Coronary stent implantation safe, feasible for infants or toddlers with ACS

Percutaneous coronary intervention (PCI) is not a generally accepted option for infants or toddlers with acute coronary syndrome. However, a new report published in the August issue of Catheterization and Cardiovascular Interventions, a journal of The Society for Cardiovascular Angiography and Interventions (SCAI), found coronary stent implantation to be a feasible and safe palliative option for children fifteen months and younger.

Kentucky, Minn., Florida, Texas facing tough Medicaid, budget decisions

Governor Steve Beshear of Kentucky has given lawmakers less than two weeks to approve his plan to come up with $165 million for Medicaid or he'll cut payments. The first-term Democrat, who took office in January 2008, faces a local variation on a problem vexing governors across the U.S.: when Kentucky lawmakers approved an $18 billion biennial budget last year, they overestimated federal Medicaid funding.

Santarus, Cosmo announce positive results from budesonide MMX Phase III study in ulcerative colitis

Santarus, Inc. and Cosmo Pharmaceuticals S.p.A. today announced positive top-line results from the Phase III clinical study conducted in the U.S. and India to evaluate the safety and efficacy of budesonide MMX® for the induction of remission of mild or moderate active ulcerative colitis. The study results show that budesonide MMX 9 mg taken once daily met the primary endpoint of superiority to placebo.

Carrie Jo Smith-hunter, - Occupational Therapist in Burkesville, KY